CXCR4 Chemokine Receptor Antagonists

CXCR4 chemokine receptor antagonists are a therapeutic class of agents that selectively bind to the C-X-C motif chemokine receptor 4, reversibly blocking its interaction with its endogenous ligand, stromal cell-derived factor-1

CXCR4 chemokine receptor antagonists are a therapeutic class of agents that selectively bind to the C-X-C motif chemokine receptor 4, reversibly blocking its interaction with its endogenous ligand, stromal cell-derived factor-1 This inhibition disrupts the intracellular signaling pathways responsible for the homing, retention, and chemotaxis of leukocytes and progenitor cells within the bone marrow niche Additionally, class members are used to treat WHIM syndrome, a rare primary immunodeficiency...

CXCR4 chemokine receptor antagonists are a therapeutic class of agents that selectively bind to the C-X-C motif chemokine receptor 4, reversibly blocking its interaction with its endogenous ligand, stromal cell-derived factor-1 Therapeutically, these agents are primarily indicated to mobilize hematopoietic stem cells into the peripheral blood for collection and autologous stem cell transplantation in hematologic malignancies, such as multiple myeloma and non-Hodgkin lymphoma

Therapeutically, these agents are primarily indicated to mobilize hematopoietic stem cells into the peripheral blood for collection and autologous stem cell transplantation in hematologic malignancies, such as multiple myeloma and non-Hodgkin lymphoma

Therapeutically, these agents are primarily indicated to mobilize hematopoietic stem cells into the peripheral blood for collection and autologous stem cell transplantation in hematologic malignancies, such as multiple myeloma and non-Hodgkin lymphoma

Additionally, class members are used to treat WHIM syndrome, a rare primary immunodeficiency characterized by CXCR4 receptor hyperactivity, by releasing retained mature neutrophils and lymphocytes into the circulation